724
Views
90
CrossRef citations to date
0
Altmetric
Research Article

A Review and Analysis of the Mahalanobis—Taguchi System

, , , , &
Pages 1-15 | Published online: 01 Jan 2012
 

Abstract

The Mahalanobis–Taguchi system (MTS) is a relatively new collection of methods proposed for diagnosis and forecasting using multivariate data. The primary proponent of the MTS is Genichi Taguchi, who is very well known for his controversial ideas and methods for using designed experiments. The MTS results in a Mahalanobis distance scale used to measure the level of abnormality of “abnormal” items compared to a group of “normal” items. First, it must be demonstrated that a Mahalanobis distance measure based on all available variables on the items is able to separate the abnormal items from the normal items. If this is the case, then orthogonal arrays and signal-to-noise ratios are used to select an “optimal” combination of variables for calculating the Mahalanobis distances. Optimality is defined in terms of the ability of the Mahalanobis distance scale to match a prespecified or estimated scale that measures the severity of the abnormalities. In this expository article, we review the methods of the MTS and use a case study based on medical data to illustrate them. We identify some conceptual, operational, and technical issues with the MTS that lead us to advise against its use.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.